Julie Brahmer


If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 6 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Survival Medicine & Life Sciences
Carboplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2018

Non-Small Cell Lung Carcinoma
Drug Therapy
Renal Cell Carcinoma
Non-Small Cell Lung Carcinoma

Evaluation of health-related quality of life and symptoms in patients with advanced non-squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 057

Reck, M., Brahmer, J., Bennett, B., Taylor, F., Penrod, J. R., DeRosa, M., Dastani, H., Spigel, D. R. & Gralla, R. J., Oct 1 2018, In : European Journal of Cancer. 102, p. 23-30 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Lung Neoplasms
Quality of Life
Visual Analog Scale

Five-year follow-up of nivolumab in previously treated advanced non–small-cell lung cancer: Results from the CA209-003 study

Gettinger, S., Horn, L., Jackman, D., Spigel, D., Antonia, S., Hellmann, M., Powderly, J., Heist, R., Sequist, L. V., Smith, D. C., Leming, P., Geese, W. J., Yoon, D., Li, A. & Brahmer, J., Jun 10 2018, In : Journal of Clinical Oncology. 36, 17, p. 1675-1684 10 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Survival Rate